Panel Discussions

Aura Panel Discussion August 2020

In August 2020, GENETWORx’s expert panelists gathered again to discuss the COVID-19 crisis and how GENETWORx’s new data management software Aura is helping businesses, healthcare facilities, schools, and more keep their populations safe while keeping their doors open.

In this panel discussion, you’ll learn:

  • What does Aura have to offer? Who would benefit the most from it?
  • How quickly can GENETWORx expedite test results? What is GENETWORx’s testing capacity?
  • How can businesses, universities, etc. prepare for a surge in cases?
  • What else do businesses, universities, etc. need besides testing to keep their populations safe?
  • A step-by-step demonstration of Aura and all of its features

The panelists included Steven Paolucci, CTO/Architect at GENETWORx and Matt Etheridge, VP of Sales and Marketing at GENETWORx.

“We’ve listened to the pain points, the needs of you and your patients, to figure out what we can do better. Standing still in this space is not an option. [Aura] is the next evolution of taking yet another step to develop outstanding service to our customers and the patients they provide service for. Bottom line is, testing is one thing. Question is, what else do you really need? Aura serves as a data management system, a scheduling platform, an all-encompassing program to give you exactly what they’ve been asking for,” says Matt.

Please see a free recording of the event below. If you’d like to learn more about Aura or GENETWORx’s diagnostic and antibody testing, contact our COVID-19 suppression team.

COVID-19 Panel Discussion July 2020

In July 2020, GENETWORx organized a team of expert panelists to discuss the top questions community leaders face amidst the threat of COVID-19:

  • How can organizations and schools ensure that frontline workers, faculty, students, or healthcare professionals are able to work and study safely?
  • What is needed to put a comprehensive testing and monitoring plan in place for COVID-19 suppression?
  • What are the differences between COVID-19 and Antibody testing? Does it matter which test you get?
  • What is sequential population management?
  • How does partnering with GENETWORx help make a COVID-19 suppression plan successful?

The panelists included John Hopkins, DO, President and Founder of CSS Healthcare, Steven Paolucci, CTO/Architect at GENETWORx, Sarah Jacobs-Helber, PhD, HCLD (ABB), Chief Laboratory Officer at GENETWORx, and Matt Etheridge, VP of Sales and Marketing at GENETWORx.

A free recording of this event is posted here. We encourage everyone to view and share this vital information as our country aims to find its “new normal.” Contact our COVID-19 suppression team to speak with laboratory experts about a plan for your organization.

Menu
Call Now 610-726-1205